Unlisted Shares
Royalcare Super Speciality Hospitals Limited
Royalcare Super Speciality Hospitals Limited (Unlisted)
Verified Unlisted CompanyOff-market Transfer · NSDL / CDSL
About Royalcare Super Speciality Hospitals Limited
Royalcare Super Speciality Hospitals Limited is a multi-specialty hospital based in Coimbatore, Tamil Nadu, established in 2015. The hospital provides comprehensive tertiary healthcare services with advanced infrastructure and a focus on delivering high-quality patient care across various specialties.
Share Details
| company Name | Royalcare Super Speciality Hospitals Limited (Unlisted) |
| indicative Unlisted Share Price | ₹179 |
| market Capitalization | ₹3019 Crore |
| lot Size | 1000 |
| 52 Week High | ₹160 |
| 52 Week Low | ₹125 |
| face Value | ₹10 |
| book Value | 17.37 |
| pe Ratio | 200 |
| pb Ratio | 9.21 |
| debt To Equity | 1.34 |
| return On Equity | 7.52 |
| total Outstanding Shares | 18658678 |
| isin | INE02CB01010 |
| depository | NSDL & CDSL |
| pan | AAQCR1968R |
| cin | U85100TZ2012PLC018984 |
| rta | Link Intime India |
Income Statement (Profit & Loss) (₹ in Crore)
| Particulars | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Revenue | 301 | 305 | 333 | 352 |
| EBITDA | 68 | 61 | 67 | 52 |
| PBT | 21 | 16 | 24 | 16 |
| Net Profit / Loss (PAT) | 21 | 16 | 24 | 15 |
| EPS | 1.28 | 0.97 | 1.4 | 0.8 |
Key Financial Ratios (Last 3–5 Years)
| Ratio | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Operating Profit Margin (%) | 22.59 | 20 | 20.12 | 14.77 |
| Net Profit Margin (%) | 6.98 | 5.25 | 7.21 | 4.26 |
| Earning Per Share (Diluted) | 1.28 | 0.97 | 1.4 | 0.8 |
Financial Annual Report Summary
The company has shown stable revenue growth, but profitability remains moderate with fluctuating margins. High valuation multiples and rising debt levels are key concerns despite steady operational performance.
Why Invest in Royalcare Super Speciality
- Stable revenue growth in healthcare sector.
- Declining margins in FY25 raise concerns.
- High valuation (P/E ~200) compared to earnings.
- Increasing debt levels impact financial risk.
Balance Sheet - Assets (₹ in Crore)
| Item | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Fixed Assets | 331 | 332 | 330 | 325 |
| CWIP | 10 | 12 | 82 | 285 |
| Investments | 1 | 1 | 1 | 1 |
| Trade Receivables | 9 | 17 | 23 | 23 |
| Inventory | 6.5 | 9 | 13 | 16.5 |
| Other Assets | 47.5 | 50 | 96 | 160.5 |
| Total Assets | 405 | 421 | 545 | 811 |
Balance Sheet - Liabilities & Equity (₹ in Crore)
| Item | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Share Capital | 164.37 | 164.37 | 171 | 188.65 |
| FV | 10 | 10 | 10 | 10 |
| Reserves | -16 | -31 | 24 | 129 |
| Borrowings | 256 | 243 | 291 | 425 |
| Trade Payables | 6 | 12 | 30 | 51 |
| Other Liabilities | 24.63 | 32.63 | 29 | 34.35 |
| Total Liabilities | 405 | 421 | 545 | 811 |
Liabilities Breakdown & Balance Sheet Insights
Balance Sheet Insights
Significant increase in CWIP and borrowings indicates aggressive expansion with rising financial risk.
Liabilities Breakdown
Debt to Equity ratio of 1.34 indicates relatively high leverage.
Additional Insights
Rapid asset growth driven by expansion, but accompanied by rising debt and improving reserves.
Cash Flow Insights
- Consistent operating cash flow but declining in FY25.
- Heavy investment outflows due to expansion.
- Financing inflows increased significantly due to higher borrowings.
Shareholding Pattern
Recent
Promoter: High
Institutional: Low
Public: Moderate
Promoters & Management
Promoter-driven healthcare company focused on expanding multi-specialty hospital services.
Key Management
Not Available
Registrar & Transfer Agent (RTA)
Registrar: Link Intime India
Website: https://linkintime.co.in/
Management Analysis
Focused on hospital expansion and improving healthcare infrastructure to cater to growing demand.
Frequently Asked Questions About Royalcare Super Speciality Hospitals Limited
Explore More Investment Opportunities
Discover IPOs, unlisted shares, and broker comparison tools curated for smart investors.